Kirsi Ketola

6PUBLICATIONS
22CO-AUTHORS
PharmacogenomicsSolid mechanicsMedical infection agents (incl. prions)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 12, 2025
Real-world outcomes of 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: the KuPSMALu trial in Eastern Finland.

Okko-Sakari Kääriäinen, Pekka Poutiainen, Heidi Gröhn

|Mar 21, 2025
Matrix stiffness modulates androgen response genes and chromatin state in prostate cancer.

Roosa Kaarijärvi, Heidi Kaljunen, Onni Niemi

|Mar 30, 2024
SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer.

Noora Leppänen, Heidi Kaljunen, Eerika Takala

|Jan 18, 2024
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2.

Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi

Pageof 1